ABSTRACT
INTROduCTION
Urogenital infection with Chlamydia trachomatis (CT) is the most commonly reported sexually transmitted infection (STI) and continues to be a major public health problem worldwide. Untreated CT infections can lead to serious complications, such as pelvic inflammatory disease in women and epididymitis in men (1) . Asymptomatic CT infections are common, including in men who have sex with men (MSM) who are infected with human immunodeficiency virus (HIV). (2) (3) (4) (5) ) This is thus a major clinical problem, since CT infection is regarded as an important co-factor in incident HIV infections among MSM. (6, 7) CT infection is associated with increased HIV shedding, (8, 9) and the treatment of CT urethritis reduces the seminal HIV-RNA concentrations in HIV-infected men. (10) The exact mechanisms by which CT infections increase viral shedding and why CT infections are often asymptomatic are not well understood. It has been suggested that sexually transmitted infections (STI), such as CT, enhance HIV transmission through increased release of pro-inflammatory cytokines, (8) attenuating the local mucosal immune defense.
Several studies have assessed concentrations of pro-inflammatory cytokines in CT infections and other STI. In vitro, CT has increased the concentration of cytokines in fibroblasts like synovial and epithelial cells. (11, 12) Furthermore, in vivo increases in local pro-inflammatory and anti-inflammatory cytokines in CT infections were found in cervical-lavage specimens in women (13) and on urethral swabs in men. (14, 15) Increased concentrations of cytokines were also detected in urine of men infected with Neisseria gonorrhoeae (NG) before the onset of symptoms, and they peaked at the onset of symptoms. (16) Taken together, it is likely that HIV-infected patients co-infected with CT have more pronounced local inflammation than patients with either HIV or CT infection.
In addition, HIV-infected patients, especially those who are not treated with combination antiretroviral therapy (cART), may have a decreased cellular immunity, (17) which could impede the adaptive immune response to CT and further aggravate inflammation. The enhanced inflammation, however, is not consistent with the commonly asymptomatic course of CT in HIV-infected patients. To our knowledge, mucosal damage and the inflammatory and immune response of the rectal mucosa have not been previously studied. The aim of this exploratory study is to assess whether rectal CT infection, HIV infection and use of cART affect local markers of mucosal damage (leakage) and inflammation (neutrophil activation), as well as the concentrations of several pro-inflammatory and anti-inflammatory cytokines and chemokines (IL-8, MCP-1, MIP-1β, IL-1α, IL-1β, IL-1RA, IL-6 and IL-10) in the rectum of MSM who have had receptive anal intercourse.
METHOdS

Study population
The outpatient STI clinic of the Public Health Service of Amsterdam (GGD Amsterdam) offers free and anonymous STI testing and treatment (18) . From November 2010 to February 2011, consecutive MSM attendees of the clinic who reported receptive anal sex in the preceding 6 months and who were visiting the clinic for an STI screening were invited to participate in the study. Further inclusion criteria were an age of 16 years or more and sufficient understanding of the study in Dutch or English. Before routine consultation with the nurse, the study was explained, and the patient was invited to participate. After obtaining informed consent for participation, we asked HIV-infected patients for written approval to obtain data on CD4 cell count, HIV-RNA load, and cART use from the physician treating their HIV infection. Patients who declined to permit us to obtain data from their treating physicians were still allowed to participate. We aimed to select 90 participants from the total group who gave informed consent for cytokine testing. To study the effect of CT, HIV and cART on markers of inflammation and mucosal damage and on cytokine concentrations, we intended to recruit 15 participants in each of the following 6 groups: Participants who were diagnosed with lymphogranuloma venereum, rectal gonorrhea, rectal herpes, anal warts, or non-CT proctitis were excluded. Also, participants who were diagnosed with syphilis or acute hepatitis B or C infection were excluded. For the analysis, we selected consecutive participants for each of the six groups. However, for groups consisting of HIV-infected MSM, we preferred those who permitted us to obtain data from the physician treating their HIV infection. Also, we preferred participants without any other STI except rectal CT. The medical ethics committee of the Academic Medical Center approved the study. All participants provided written informed consent.
Procedures and laboratory testing
All patients were screened for STI according to the clinic's protocol (19) . A nucleic acid amplification test (NAAT) (Gen-Probe Aptima Combo 2 Assay, Gen-Probe Incorporated, San Diego, USA) was used for the diagnosis of Chlamydia trachomatis. An additional anal swab for cytokine measurements was taken from all participants with a dry cotton tip swab before the standard rectal swabs for CT and NG tests. When there is substantial leakage across the rectal mucosa, Q Alb should not be used to adjust for dilution of the mucosal-lining fluid. To check whether there was substantial leakage, we also assessed alpha-2-macroglobulin (A2M). A2M is a large molecule in the circulation, and its passage across the mucosal membrane is more restricted than that of albumin, unless there is mucosal leakage (21) . This mucosal leakage can We also plotted MPO against IL-8 for CT-negative participants and CT-positive participants to assess whether there were differences in MPO increases in reaction to IL-8 increases; IL-8 is a major chemokine for neutrophil recruitment and activation, and increases of IL-8 should correspond with increases in MPO.
Data analyses were performed with STATA 11.2 (STATA Intercooled, College Station, TX, USA). Differences were significant at P value ≤0.05 and near-significant at P value >0.05 and ≤0.1. In figures, a log10-scale was used. Adjusted values are presented, unless indicated otherwise.
RESulTS
Study population
Of 961 MSM who were screened for eligibility, 288 were excluded, because they reported not having had receptive anal sex in the 6 months preceding the study visit (flowchart, Figure 1 ). Of the 673 eligible MSM, 91 (13.5%) refused to participate. Of the remaining MSM, 79 consecutive participants were selected for groups A to F.
The numbers in each group do not total exactly 15, as too few men fit the criteria for some groups (E & F) and some men ultimately had a different HIV and cART status than was initially reported (B & C). Participant characteristics are depicted in Table   1 . MPO, Alb, A2M or cytokine concentrations could not be analysed in samples of three participants. Only five (6.3%) MSM had self-reported rectal symptoms, such as itching or discharge; four of the five were diagnosed with rectal CT infection.
Data on plasma HIV-RNA and CD4 cell count were missing for participants who were newly diagnosed with HIV (n=7) and for participants who declined to give permission for obtaining information about plasma HIV-RNA and CD4 counts from the physician treating their HIV infection (n=7). One HIV-infected participant had never received cART, but nevertheless, he had an undetectable viral load.
Chapter 5 figures and tables 
Markers of mucosal damage
There were no significant differences in Q A2M , Q Alb and RCE between groups ( Figure   2 ). The relationship between Q A2M and Q Alb in sampled mucosal fluids is shown in Supplemental Content 2. The correlation between Q A2M and Q Alb indicated no mucosal leakage and thus adjustment by Q Alb for dilution of mucosal-lining fluid was justified.
Only one sample deviated markedly from the fitted line, which suggest that the mucosal barrier was reduced for this participant. Figure 2 shows the MPO concentrations for each group. There were no significant differences in MPO concentrations between groups. Q A2M and RCE correlated with MPO (not shown): spearman ρ = 0.6 and ρ = 0.5, respectively), suggestive of neutrophil activation causing mucosal damage.
Markers of inflammation
Cytokine concentrations
Concentrations of pro-inflammatory and anti-inflammatory cytokines are shown by group in Figure 3 , and differences between the groups below p<0. showed (near-)significant differences.
Influence of CT on cytokine concentrations
Among HIV-negative participants, median concentrations of MCP-1, IL-1α and IL-1RA
were unexpectedly higher (at P value <0.1) in those without rectal CT (group A) as compared to those with CT (group D). In HIV-infected participants, there were no differences in median concentrations of cytokines between those without and those with rectal CT infection.
Influence of HIV, and of cART, on cytokine concentrations
In participants with rectal CT infection, HIV-negative MSM (group D) appeared to have lower median concentrations of IL-8 and IL-1α than participants with HIV (groups E+F) (unadjusted P=0.09 and unadjusted P=0.04). Adjustment of concentrations for dilution resulted in similar differences (P=0.06 and P=0.05). There were no differences in median cytokine concentrations between HIV-infected participants with and without cART, irrespective of the presence or absence of CT infection.
Asymptomatic versus symptomatic patients
The median concentrations of IL-6 and IL-10 were higher in asymptomatic patients (n=74) than the median concentrations in patients with symptoms (n=5) (P=0.04 and P=0.01; adjusted IL-6 (0.8 vs.0.2 pg/ml) and adjusted IL-10 (0.3 vs. 0.01 pg/ml)).
MPO and IL-8 concentrations
Since IL-8 is a major chemokine for neutrophil recruitment and activation, we 
dISCuSSION
The most important finding in this study is that mucosal damage and neutrophil inflammation were not different between patients with or without CT, HIV and cART.
Interestingly, CT infection was associated with a suppressed cytokine (IL-8, MCP-1, IL-1α and IL-1RA) expression in HIV-negative patients, but not in those infected with HIV (IL-8 and IL-1α ). CT infection also was associated with an attenuated neutrophil response to IL-8, which may explain why there was no difference in inflammation and mucosal damage between the patient groups. To our knowledge, this is the first report of a study on rectal cytokine concentrations and rectal parameters of inflammation. We found that rectal CT infection in MSM is not paralleled by enhanced inflammation, which may explain why rectal CT infections are often asymptomatic.
Influence of CT, HIV and cArT on mucosal damage and inflammation
In vitro and in vivo studies have suggested that CT infection in the urethra and vagina leads to increased release of inflammatory mediators (24) (25) (26) , and thus, we expected an increased local inflammatory response and mucosal damage in participants with rectal CT infection. We used Q A2M , Q Alb and RCE (Q A2M /Q Alb ) as markers of rectal mucosal damage and MPO concentration as a marker of the neutrophil inflammatory response. There were, however, no significant differences for these parameters, indicating no difference in mucosal damage between the patient groups. The correlation between Alb and A2M in rectal samples and the correlation between MPO and markers of mucosal damage underscore that these findings are genuine.
Since mechanical stress can lead to inflammation (27) , local mechanical stress in the rectum caused by receptive anal sex may have overshadowed differences in markers of mucosal damage and inflammation between the groups.
Influence of CT, HIV and cArT on cytokine concentration
CT infection in HIV-infected MSM neither reduced nor increased cytokine concentrations. In HIV-negative MSM, however, we found reduced cytokine concentrations in those with CT infection as opposed to those without CT infection.
These results are not due to the adjustment for dilution, since three out of the five unadjusted values already showed (near-) significant differences. In previous studies, CT-infected epithelial cells were found to release more IL-1α (28) , and CT infections of the urethra and cervix displayed increased IL-6, IL-8 and IL-10 concentrations (24) (25) (26) 28, 29) . It is probable that the microbial load in the gastrointestinal tract is increased over that in the cervix and urethra (30) , which may underlie the observed differences in inflammatory response to CT infection between the rectum and the cervix and urethra. An alternative explanation for the reduced cytokine concentrations in CT-infected HIV-negative patients is that CT infection induces indoleamine 2,3-dioxygenase (IDO) activity that inhibits immune responses (31) .
Since IDO expression is dependent on T-cell activation, a reduced T-cell response, as may occur in HIV-infected individuals, can prevent induction of the inhibitory effect of IDO. The lack of difference in cytokine concentrations between HIV-infected MSM with or without CT infection in our study supports that explanation.
In HIV-infected participants with rectal CT infection in our study, median cytokine concentrations did not differ between MSM who used cART and those who were not using it. This lack of difference is in contrast to a study in HIV-infected women without CT (32) that showed that concentrations of TNF-α, IL-6 and IL-1β in cervical lavages decreased after initiation of cART. Our results may also be explained by the absence of a difference in immune status. In our participants with and without cART, all had relatively high concentrations of CD4 + T cells; the median circulating CD4 + T cells were 670 and 460 cells/mm 3 , respectively.
Asymptomatic versus symptomatic participants
Most CT-infected participants (88%) were asymptomatic in our study. In another study, increased concentrations of cytokines were detected in the urine of NG-infected men before the onset of symptoms, and these concentrations peaked simultaneously with the onset of symptoms (16) . The lack of symptoms in those with CT infection in our study might be explained by the fact that cytokine concentrations did not differ in HIV-infected MSM with and without CT infection and were reduced in HIV-negative MSM infected with CT. Another explanation is that the median concentrations of IL-6
and IL-10 were higher in asymptomatic participants. Since IL-6 and IL-10 can have anti-inflammatory effects, increased concentrations of these cytokines may lead to a decreased inflammatory response and, therefore, fewer symptoms.
A limitation of this study is the low number of participants in each group. As a result, the power of the study was limited, which means that we might have missed important differences. Since there were no data available on cytokine concentrations in rectal fluid, we performed no calculations for sample size. This was a pilot study, is not paralleled by enhanced inflammation, which may explain why CT infections are often asymptomatic. Further study is required to clarify the exact process by which CT escapes the mechanisms in the rectum that initiate inflammation and eradication of a pathogen.
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